Article info
Pancreas
Original research
Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours
- Correspondence to Dr Yunching Chen, Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, Taiwan; yunching{at}mx.nthu.edu.tw; Dr Tsai-Te Lu, Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, Taiwan; ttlu{at}mx.nthu.edu.tw; Dr Jane Wang, Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan; janewang{at}mx.nthu.edu.tw
Citation
Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours
Publication history
- Received May 17, 2021
- Accepted November 29, 2021
- First published December 17, 2021.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.